Published in Am J Obstet Gynecol on March 01, 2004
Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat Cell Biol (2003) 7.02
Living with or without cyclins and cyclin-dependent kinases. Genes Dev (2004) 6.54
A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med (2008) 5.11
CDK inhibitors: cell cycle regulators and beyond. Dev Cell (2008) 5.07
High prevalence of vitamin D insufficiency in black and white pregnant women residing in the northern United States and their neonates. J Nutr (2007) 4.61
Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab (2007) 4.16
Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation. Mol Cell (2003) 3.91
A new description of cellular quiescence. PLoS Biol (2006) 3.56
Pregnancy outcomes with weight gain above or below the 2009 Institute of Medicine guidelines. Obstet Gynecol (2013) 3.46
p27Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev (2004) 3.16
Kinase-independent function of cyclin E. Mol Cell (2007) 3.03
Discovery of an oncogenic activity in p27Kip1 that causes stem cell expansion and a multiple tumor phenotype. Genes Dev (2007) 3.00
p27kip1 independently promotes neuronal differentiation and migration in the cerebral cortex. Genes Dev (2006) 2.89
Ubiquitin-independent degradation of cell-cycle inhibitors by the REGgamma proteasome. Mol Cell (2007) 2.38
Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA (2002) 2.36
Control of the reversibility of cellular quiescence by the transcriptional repressor HES1. Science (2008) 2.29
Subclassification of preeclampsia. Hypertens Pregnancy (2003) 2.25
The risk of preeclampsia rises with increasing prepregnancy body mass index. Ann Epidemiol (2005) 2.12
A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression. Genes Dev (2006) 2.05
Regulation of the cytoskeleton: an oncogenic function for CDK inhibitors? Nat Rev Cancer (2004) 1.99
Preventing and treating eclamptic seizures. BMJ (2002) 1.88
p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy. J Natl Cancer Inst (2006) 1.74
Periconceptional multivitamin use reduces the risk of preeclampsia. Am J Epidemiol (2006) 1.70
First-trimester prediction of preeclampsia in nulliparous women at low risk. Obstet Gynecol (2012) 1.66
Maternal serum 25-hydroxyvitamin D concentrations are associated with small-for-gestational age births in white women. J Nutr (2010) 1.64
Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor. J Clin Endocrinol Metab (2005) 1.61
A mouse model for cyclin E-dependent genetic instability and tumorigenesis. Cancer Cell (2005) 1.59
Prepregnancy body mass index and the occurrence of severe hypertensive disorders of pregnancy. Epidemiology (2007) 1.58
A pilot study of the effects of phytoestrogen supplementation on postmenopausal endometrium. J Soc Gynecol Investig (2002) 1.57
Seroprevalence of antibodies to Chlamydia pneumoniae in women with preeclampsia. Obstet Gynecol (2003) 1.57
Inflammation and dyslipidemia related to risk of spontaneous preterm birth. Am J Epidemiol (2007) 1.57
Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia. Hypertension (2007) 1.56
Race Disparities and Decreasing Birth Weight: Are All Babies Getting Smaller? Am J Epidemiol (2015) 1.53
N-acetylation and ubiquitin-independent proteasomal degradation of p21(Cip1). Mol Cell (2004) 1.45
First trimester exposure to ambient air pollution, pregnancy complications and adverse birth outcomes in Allegheny County, PA. Matern Child Health J (2013) 1.44
Preeclampsia--a pressing problem: an executive summary of a National Institute of Child Health and Human Development workshop. Reprod Sci (2007) 1.42
Early pregnancy lipid concentrations and spontaneous preterm birth. Am J Obstet Gynecol (2007) 1.40
Prepregnancy obesity predicts poor vitamin D status in mothers and their neonates. J Nutr (2007) 1.37
Cooperative regulation of the cell division cycle by the protein kinases RAF and AKT. Mol Cell Biol (2004) 1.35
Uric acid concentrations in early pregnancy among preeclamptic women with gestational hyperuricemia at delivery. Am J Obstet Gynecol (2006) 1.34
Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance. J Clin Endocrinol Metab (2004) 1.34
Accuracy and reliability of maternal recall of infant birth weight among older women. Ann Epidemiol (2005) 1.33
Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk. Am J Physiol Heart Circ Physiol (2004) 1.30
Redefining preeclampsia using placenta-derived biomarkers. Hypertension (2013) 1.30
Association of periconceptional multivitamin use and risk of preterm or small-for-gestational-age births. Am J Epidemiol (2007) 1.29
Cyclin I activates Cdk5 and regulates expression of Bcl-2 and Bcl-XL in postmitotic mouse cells. J Clin Invest (2009) 1.28
Strategy for standardization of preeclampsia research study design. Hypertension (2014) 1.25
Cyclin E phosphorylation regulates cell proliferation in hematopoietic and epithelial lineages in vivo. Genes Dev (2008) 1.25
Prepregnancy lipids related to preterm birth risk: the coronary artery risk development in young adults study. J Clin Endocrinol Metab (2010) 1.22
Cigarette smoke exposure and angiogenic factors in pregnancy and preeclampsia. Am J Hypertens (2008) 1.22
The Preterm Prediction Study: the value of serum alkaline phosphatase, alpha-fetoprotein, plasma corticotropin-releasing hormone, and other serum markers for the prediction of spontaneous preterm birth. Am J Obstet Gynecol (2002) 1.22
Excessive early gestational weight gain and risk of gestational diabetes mellitus in nulliparous women. Obstet Gynecol (2012) 1.20
How disturbed sleep may be a risk factor for adverse pregnancy outcomes. Obstet Gynecol Surv (2009) 1.20
Particulate air pollution exposure and C-reactive protein during early pregnancy. Epidemiology (2011) 1.19
A Skp2 autoinduction loop and restriction point control. J Cell Biol (2007) 1.18
Family history of hypertension, heart disease, and stroke among women who develop hypertension in pregnancy. Obstet Gynecol (2003) 1.16
Early occurrence of metabolic syndrome after hypertension in pregnancy. Obstet Gynecol (2005) 1.13
Testing the importance of p27 degradation by the SCFskp2 pathway in murine models of lung and colon cancer. Proc Natl Acad Sci U S A (2006) 1.12
Improving internal medicine residents' performance, knowledge, and confidence in central venous catheterization using simulators. J Hosp Med (2009) 1.11
Maternal serum oestrogen and androgen concentrations in preeclamptic and uncomplicated pregnancies. Int J Epidemiol (2003) 1.09
Preterm delivery and later maternal cardiovascular disease risk. Epidemiology (2007) 1.09
Coupling cell cycle exit, neuronal differentiation and migration in cortical neurogenesis. Cell Cycle (2006) 1.08
Interleukin-6 promoter -174 polymorphism and spontaneous preterm birth. Am J Obstet Gynecol (2003) 1.08
MAD1 and p27(KIP1) cooperate to promote terminal differentiation of granulocytes and to inhibit Myc expression and cyclin E-CDK2 activity. Mol Cell Biol (2002) 1.07
Separation of telomerase functions by reverse genetics. Proc Natl Acad Sci U S A (2011) 1.07
Hijacking HES1: how tumors co-opt the anti-differentiation strategies of quiescent cells. Trends Mol Med (2009) 1.07
Maternal insulin resistance and preeclampsia. Am J Obstet Gynecol (2011) 1.06
First trimester adipocytokine concentrations and risk of developing gestational diabetes later in pregnancy. Clin Endocrinol (Oxf) (2008) 1.06
Endothelial junctional protein redistribution and increased monolayer permeability in human umbilical vein endothelial cells isolated during preeclampsia. Am J Obstet Gynecol (2002) 1.05
Maternal vitamin D status and the risk of mild and severe preeclampsia. Epidemiology (2014) 1.05
Inflammation and triglycerides partially mediate the effect of prepregnancy body mass index on the risk of preeclampsia. Am J Epidemiol (2005) 1.03
Racial/ethnic differences in the monthly variation of preeclampsia incidence. Am J Obstet Gynecol (2007) 1.02
Correlation of serum hormone concentrations in maternal and umbilical cord samples. Cancer Epidemiol Biomarkers Prev (2003) 1.02
Cyclin I protects podocytes from apoptosis. J Biol Chem (2006) 1.01
Uric acid concentrations are associated with insulin resistance and birthweight in normotensive pregnant women. Am J Obstet Gynecol (2009) 1.00
Uric acid attenuates trophoblast invasion and integration into endothelial cell monolayers. Am J Physiol Cell Physiol (2009) 1.00
Vitamin C and E supplementation to prevent spontaneous preterm birth: a randomized controlled trial. Obstet Gynecol (2010) 0.99
Contemporary management of preterm premature rupture of membranes: determinants of latency and neonatal outcome. Am J Perinatol (2004) 0.98
Prior preterm or small-for-gestational-age birth related to maternal metabolic syndrome. Obstet Gynecol (2011) 0.96
Low placental growth factor across pregnancy identifies a subset of women with preterm preeclampsia: type 1 versus type 2 preeclampsia? Hypertension (2012) 0.96
Maternal leptin across pregnancy in women with small-for-gestational-age infants. Am J Obstet Gynecol (2007) 0.96
The utility of uterine artery Doppler velocimetry in prediction of preeclampsia in a low-risk population. Obstet Gynecol (2012) 0.96
Air quality implications of the Deepwater Horizon oil spill. Proc Natl Acad Sci U S A (2011) 0.95
Homocysteine and folic acid are inversely related in black women with preeclampsia. Hypertension (2004) 0.95
Variability in cerebral oxygen delivery is reduced in premature neonates exposed to chorioamnionitis. Pediatr Res (2006) 0.94
The NICHD-MFMU antibiotic treatment of preterm PROM study: impact of initial amniotic fluid volume on pregnancy outcome. Am J Obstet Gynecol (2006) 0.94
Oxidative stress in preeclampsia. Am J Obstet Gynecol (2004) 0.94
Fatty aldehydes in cyanobacteria are a metabolically flexible precursor for a diversity of biofuel products. PLoS One (2013) 0.93
Regulation of cyclin-dependent kinase activity during mitotic exit and maintenance of genome stability by p21, p27, and p107. Proc Natl Acad Sci U S A (2004) 0.93
Use of simulator-based medical procedural curriculum: the learner's perspectives. BMC Med Educ (2010) 0.93
Angiotensin II decreases system A amino acid transporter activity in human placental villous fragments through AT1 receptor activation. Am J Physiol Endocrinol Metab (2006) 0.93
Preeclampsia and soluble fms-like tyrosine kinase 1. J Clin Endocrinol Metab (2009) 0.92
A mechanism misregulating p27 in tumors discovered in a functional genomic screen. PLoS Genet (2007) 0.92
Anxiety and optimism associated with gestational age at birth and fetal growth. Matern Child Health J (2010) 0.92
Critical pathways for the management of preeclampsia and severe preeclampsia in institutionalised health care settings. BMC Pregnancy Childbirth (2003) 0.91
Cyclin A promotes S-phase entry via interaction with the replication licensing factor Mcm7. Mol Cell Biol (2010) 0.90
C-reactive protein is elevated 30 years after eclamptic pregnancy. Hypertension (2008) 0.90
Prevalence of sleep deficiency in early gestation and its associations with stress and depressive symptoms. J Womens Health (Larchmt) (2013) 0.90
First trimester uric acid and adverse pregnancy outcomes. Am J Hypertens (2011) 0.90